Riverside-backed InVita Invests in STACS DNA
May 18, 2021
The Riverside Company has invested in STACS DNA as an add-on to its InVita Healthcare Technologies platform; InVita (backed by Riverside) will integrate STACS DNA's sample-tracking and lab management software into its suite for complex medical environments. STACS DNA, headquartered in Ottawa, Ontario, provides forensic and healthcare sample-tracking solutions used by customers such as the FBI, RCMP and Merck to improve laboratory workflows, compliance and patient safety.
- Buyers
- The Riverside Company, InVita Healthcare Technologies
- Targets
- STACS DNA
- Platforms
- InVita Healthcare Technologies
- Industry
- Software
- Location
- Ontario, Canada
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Riverside Adds Transplant Connect to InVita Healthcare Technologies Platform
January 18, 2022
Healthcare Services
The Riverside Company has invested in Transplant Connect, maker of the iTransplant software platform, as an add-on to Riverside’s healthcare software platform InVita Healthcare Technologies. Transplant Connect, founded in 2003 and based in Los Angeles, provides clinical information management, communications, analytics and logistics across the lifecycle of human biologic donation and transplantation.
-
InVita Healthcare Technologies / The Riverside Company Acquire BloodHub
October 6, 2022
Cloud & SaaS
InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
-
The Riverside Company Invests in HemaTerra Technologies
April 18, 2019
Cloud & SaaS
The Riverside Company has invested in HemaTerra Technologies, a provider of cloud-based SaaS solutions for blood and plasma collection centers, hospitals and related healthcare organizations. Riverside said it will invest in product development, sales and marketing, and strategic partnerships to scale HemaTerra's offerings and support continued growth.
-
The Riverside Company Invests in Champion Healthcare Technologies and Combines It with HemaTerra
June 6, 2019
Cloud & SaaS
The Riverside Company has invested in Champion Healthcare Technologies and combined it with HemaTerra Technologies (a company Riverside invested in earlier) to form a leading medical specialty software business. The combined firm will provide SaaS solutions for implant lifecycle management and blood/plasma collection operations, serving over 500 hospitals and numerous independent blood and plasma centers across the United States.
-
In Vitro Sciences (Sverica) Partners with InVia Fertility Specialists
August 26, 2020
Healthcare Services
In Via Fertility Specialists has entered a partnership with In Vitro Sciences, a portfolio company of Sverica Capital Management, with Dresner Partners advising InVia on the transaction. InVia — a four-location fertility clinic group in the Chicagoland area with an on-site embryology lab and three reproductive endocrinologists — will gain strategic, operational and financial resources to support growth and enhance patient care.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.